T-Cypher Bio

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

3T Biosciences

The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Epana Bio

This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.

ImmPACT Bio

This clinical-stage biotechnology company develops logic-gate-based chimeric antigen receptor T-cell therapies for patients with cancer and autoimmune diseases.

Immunocore

This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

CDR-Life

The company develops antibody-based T cell engagers to treat patients with solid tumours and autoimmune diseases.